Resources

Supporting governments and partners across Africa to enhance surveillance systems for vaccine-preventable diseases. Through a regional assessment initiative, we evaluated digital readiness, system capacity, and data quality to identify opportunities to strengthen surveillance for better disease detection, reporting, and response.

This factsheet focuses on the development of BABE—a low-cost bubble continuous positive airway pressure (bCPAP) device with oxygen blenders to help babies with respiratory distress syndrome. BABE is designed to provide bCPAP therapy to preterm newborns without requiring a power source (i.e., electricity or battery) or medical-grade compressed air.

PATH’s Center for Advocacy and Policy convened a two-part webinar series to examine how Africa can sustain and accelerate maternal, newborn, and child health (MNCH) progress amid shrinking global aid.Part 1: MNCH Financing in Africa – This session explored the shifting aid dynamics shaping MNCH and highlighted the urgent need for sustainable funding, collective action, and innovative partnerships.Part 2: Accelerating Progress Despite Declining Aid – The second session examined what shrinking development assistance means for MNCH in Africa and how countries can adapt. Speakers emphasized the importance of regional leadership, domestic resource mobilization, and innovative partnerships to ensure health systems remain strong and resilient in the face of declining aid.Watch the recordings below to learn more about the evolving aid landscape and strategies to secure a healthier future for women and children in Africa.

According to the World Health Organization, medical oxygen is one of the key essential medicines required for multiple health conditions, including asthma, heart failure, and various newborn complications. Over the last decade, the Ugandan government has worked to improve access to medical oxygen. The National Scale Up of Medical Oxygen Implementation Plan (2018–2022), launched in 2019, guided this progress, which included increasing manufacturing capacity and installing oxygen plants at referral hospitals.

Immunization is one of the most impactful and cost-effective public health interventions available, saving up to 4 million lives every year, according to the World Health Organization (WHO). In addition to its direct impact on the health of populations, immunization brings added value by reducing the burden of disease on individuals, families, and communities.